RenaissanceRe (RNR) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
20 May, 2026Corporate overview and strategy
Operates as a leading global reinsurer with a diversified underwriting portfolio across property, casualty, and specialty risk since 1993.
Demonstrates a strong track record of organic growth and strategic acquisitions, including Platinum, Tokio Millennium Re, and Validus.
Maintains robust financial strength ratings (S&P: A+, AM Best: A+ as of February 2025).
Purpose is to protect communities and enable prosperity, with a vision to be the best underwriter and a mission to match desirable risk with efficient capital.
Executive leadership team averages 16 years of tenure, supporting stability and expertise.
Financial performance and key metrics
Gross premiums written grew to $11.7B in 2024, with net premiums written at $9.95B.
Common shareholders' equity reached $9.82B, and book value per share plus accumulated dividends was $224.
Return on average common equity (ROACE) was 19.3%, and operating ROACE was 23.5% for 2024.
Combined ratio improved to 83.9% in 2024, indicating strong underwriting profitability.
Net income available to common shareholders was $1.8B, with operating income at $2.2B.
Business segments and diversification
Property segment gross premiums written were $4.8B in 2024, with a combined ratio of 57.2%.
Casualty and specialty segment gross premiums written reached $6.9B, with a five-year average combined ratio of 98.2%.
2024 gross premiums written by geography: 51% U.S. and Caribbean, 37% worldwide, 5% Europe, 3% worldwide (ex U.S.), 2% Japan, Australia, and New Zealand, 2% other.
2024 gross premiums written by line: 26% catastrophe, 21% other specialty, 19% general casualty, 10% professional liability, 8% credit, 16% other property.
Latest events from RenaissanceRe
- Q3 2025 saw $907.7M net income, 34.9% ROE, and strong capital returns.RNR
Q3 202520 May 2026 - $2.6B net income, $1.9B operating income, 30.8% tangible book value growth in 2025.RNR
Q4 202520 May 2026 - Q2 2025 net income $826.5M, 33.7% ROE, 75.1% combined ratio, record underwriting and book growth.RNR
Q2 202520 May 2026 - Q1 2026 profit surged on strong underwriting, investment, and disciplined capital management.RNR
Q1 202620 May 2026 - Strong growth, diversification, and profitability driven by acquisitions and risk-focused strategy.RNR
Investor presentation17 Apr 2026 - Approval of a new long-term incentive plan is sought to support growth and align interests.RNR
Proxy filing10 Apr 2026 - Key votes include director elections, executive pay, incentive plan, and auditor appointment.RNR
Proxy Filing18 Mar 2026 - 2025 saw record returns, board refreshment, and enhanced ESG focus, with all proposals recommended for approval.RNR
Proxy Filing18 Mar 2026 - Q2 2024 saw $495M net income, 29% premium growth, and strong returns from Validus.RNR
Q2 20242 Feb 2026